Foresite Capital Management III as of Sept. 30, 2018
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 24 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 23.2 | $105M | 1.7M | 61.55 | |
| Immunomedics | 12.4 | $56M | 2.7M | 20.83 | |
| Alder Biopharmaceuticals | 10.8 | $49M | 2.9M | 16.65 | |
| Arcus Biosciences Incorporated (RCUS) | 10.6 | $48M | 3.4M | 13.94 | |
| Myokardia | 5.4 | $24M | 372k | 65.20 | |
| Aimmune Therapeutics | 4.8 | $22M | 801k | 27.28 | |
| Cymabay Therapeutics | 3.8 | $17M | 1.6M | 11.08 | |
| Blueprint Medicines (BPMC) | 3.4 | $16M | 200k | 78.06 | |
| Acceleron Pharma | 3.2 | $14M | 251k | 57.23 | |
| Ascendis Pharma A S (ASND) | 3.0 | $14M | 192k | 70.86 | |
| Replimune Group (REPL) | 2.8 | $13M | 780k | 16.10 | |
| Audentes Therapeutics | 2.8 | $13M | 315k | 39.59 | |
| Solid Biosciences | 2.5 | $11M | 238k | 47.18 | |
| Epizyme | 2.1 | $9.7M | 918k | 10.60 | |
| Achaogen | 2.1 | $9.5M | 2.4M | 3.99 | |
| Verona Pharma Plc ads (VRNA) | 1.4 | $6.3M | 501k | 12.51 | |
| Pacific Biosciences of California (PACB) | 1.4 | $6.1M | 1.1M | 5.41 | |
| Aclaris Therapeutics (ACRS) | 1.0 | $4.5M | 312k | 14.52 | |
| Sangamo Biosciences (SGMO) | 1.0 | $4.5M | 266k | 16.95 | |
| Biohaven Pharmaceutical Holding | 0.9 | $4.0M | 106k | 37.55 | |
| Wave Life Sciences (WVE) | 0.6 | $2.5M | 50k | 50.00 | |
| Tocagen | 0.5 | $2.3M | 149k | 15.59 | |
| BioDelivery Sciences International | 0.4 | $1.8M | 630k | 2.80 | |
| Ardelyx (ARDX) | 0.1 | $567k | 130k | 4.35 |
